Filters: Keyword is HIV Infections [Clear All Filters]
"The impact of patient race on clinical decisions related to prescribing HIV pre-exposure prophylaxis (PrEP): assumptions about sexual risk compensation and implications for access." AIDS and behavior 18, no. 2 (2014): 226-40. Abstract
"Diagnosis disclosure, medication hiding, and medical functioning among perinatally infected, HIV-positive children and adolescents." AIDS care 24, no. 9 (2012): 1092-6. Abstract
"Collective efficacy and HIV prevention in South African townships." Journal of community health 38, no. 5 (2013): 885-93. Abstract
"When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study." Annals of internal medicine 154, no. 8 (2011): 509-15. Abstract
"HIV infection and the risk of diabetes mellitus." AIDS (London, England) 23, no. 10 (2009): 1227-34. Abstract
"Risk of diabetes in HIV infected veterans pre- and post-HAART and the role of HCV coinfection." Hepatology (Baltimore, Md.) 40, no. 1 (2004): 115-9. Abstract
"Risk of heart failure with human immunodeficiency virus in the absence of prior diagnosis of coronary heart disease." Archives of internal medicine 171, no. 8 (2011): 737-43. Abstract
"A comparison of treatment eligibility for hepatitis C virus in HCV-monoinfected versus HCV/HIV-coinfected persons in electronically retrieved cohort of HCV-infected veterans." AIDS research and human retroviruses 27, no. 9 (2011): 973-9. Abstract
"Assessing social risks prior to commencement of a clinical trial: due diligence or ethical inflation?" The American journal of bioethics : AJOB 9, no. 11 (2009): 48-54. Abstract
"Addressing the "risk environment" for injection drug users: the mysterious case of the missing cop." The Milbank quarterly 82, no. 1 (2004): 125-56. Abstract
"The case against criminalization of HIV transmission." JAMA : the journal of the American Medical Association 300, no. 5 (2008): 578-81.
"The impact of episodic CD4 cell count-guided antiretroviral therapy on quality of life." Journal of acquired immune deficiency syndromes (1999) 47, no. 2 (2008): 185-93. Abstract
"Episodic antiretroviral therapy increases HIV transmission risk compared with continuous therapy: results of a randomized controlled trial." Journal of acquired immune deficiency syndromes (1999) 49, no. 2 (2008): 142-50. Abstract
"Empirical science meets moral panic: an analysis of the politics of needle exchange." Journal of public health policy 24, no. 3-4 (2003): 427-44. Abstract
"Neighborhood differences in patterns of syringe access, use, and discard among injection drug users: implications for HIV outreach and prevention education." Journal of urban health : bulletin of the New York Academy of Medicine 80, no. 3 (2003): 438-54. Abstract
"Ethical dilemmas created by the criminalization of status behaviors: case examples from ethnographic field research with injection drug users." Health education & behavior : the official publication of the Society for Public Health Education 29, no. 1 (2002): 30-42. Abstract
"Integrated, home-based treatment for MDR-TB and HIV in rural South Africa: an alternate model of care." The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 16, no. 8 (2012): 998-1004. Abstract
"Culture conversion among HIV co-infected multidrug-resistant tuberculosis patients in Tugela Ferry, South Africa." PloS one 6, no. 1 (2011): e15841. Abstract
"HIV treatment access and scale-up for delivery of opiate substitution therapy with buprenorphine for IDUs in Ukraine--programme description and policy implications." The International journal on drug policy 18, no. 4 (2007): 326-8. Abstract
"Editorial comment: why treat three conditions when it is one patient?" The AIDS reader 13, no. 8 (2003): 378-9.
"Methadone as HIV prevention: high volume methadone sites to decrease HIV incidence rates in resource limited settings." The International journal on drug policy 21, no. 2 (2010): 122-4. Abstract
"Three case reports of a clinical pharmacokinetic interaction with buprenorphine and atazanavir plus ritonavir." AIDS (London, England) 20, no. 5 (2006): 783-4.
"Lessons from Tanzania on the integration of HIV and tuberculosis treatments into methadone assisted treatment." The International journal on drug policy 25, no. 1 (2014): 22-5. Abstract
"Is it time for treatment as prevention among people who inject drugs?" Journal of acquired immune deficiency syndromes (1999) 63, no. 5 (2013): 545-7.
"A review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practice." Expert review of clinical pharmacology 6, no. 3 (2013): 249-69. Abstract
"Case series of buprenorphine injectors in Kuala Lumpur, Malaysia." The American journal of drug and alcohol abuse 34, no. 4 (2008): 511-7. Abstract
"Pharmacokinetic interactions between buprenorphine/naloxone and once-daily lopinavir/ritonavir." Journal of acquired immune deficiency syndromes (1999) 54, no. 5 (2010): 511-4. Abstract
"Medical interventions for addictions in the primary care setting." Topics in HIV medicine : a publication of the International AIDS Society, USA 18, no. 1 (2010): 8-12. Abstract
"Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone." Drug and alcohol dependence 105, no. 3 (2009): 234-9. Abstract
"Clinical care of the HIV-infected drug user." Infectious disease clinics of North America 21, no. 1 (2007): 149-79, ix. Abstract
"Medication-assisted treatment and HIV/AIDS: aspects in treating HIV-infected drug users." AIDS (London, England) 24, no. 3 (2010): 331-40. Abstract
"Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: implications and management for clinical practice." Journal of acquired immune deficiency syndromes (1999) 41, no. 5 (2006): 563-72. Abstract
"Additional explanation for lack of pharmacodynamic interaction between atazanavir and buprenorphine reported by Vergara-Rodriquez et al." Journal of acquired immune deficiency syndromes (1999) 58, no. 4 (2011): e112; author reply e112-3.
"Alcohol use in adolescents whose fathers abuse drugs." Journal of addictive diseases 22, no. 1 (2003): 11-34. Abstract
"Increasing drug users' adherence to HIV treatment: results of a peer-driven intervention feasibility study." Social science & medicine (1982) 55, no. 2 (2002): 235-46. Abstract
"Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohort." AIDS (London, England) 20, no. 3 (2006): 323-31. Abstract
"Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies." AIDS (London, England) 21, no. 12 (2007): 1579-89. Abstract
"Estimating the proportion of patients infected with HIV who will die of comorbid diseases." The American journal of medicine 118, no. 8 (2005): 890-8. Abstract
"Is antiretroviral therapy cost-effective in South Africa?" PLoS medicine 3, no. 1 (2006): e60.
"Incorporating quality of evidence into decision analytic modeling." Annals of internal medicine 146, no. 2 (2007): 133-41. Abstract
"Adjusting alcohol quantity for mean consumption and intoxication threshold improves prediction of nonadherence in HIV patients and HIV-negative controls." Alcoholism, clinical and experimental research 32, no. 9 (2008): 1645-51. Abstract
"Quantifying the decrement in utility from perceived side effects of combination antiretroviral therapies in patients with HIV." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 11, no. 5 (2008): 975-9. Abstract
"Alternative antiretroviral monitoring strategies for HIV-infected patients in east Africa: opportunities to save more lives?" Journal of the International AIDS Society 14 (2011): 38. Abstract
"Do benefits of earlier antiretroviral treatment initiation outweigh harms for individuals at risk for poor adherence?" Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 48, no. 6 (2009): 822-6. Abstract
"A framework for tailoring clinical guidelines to comorbidity at the point of care." Archives of internal medicine 167, no. 21 (2007): 2361-5. Abstract
"Influence of alternative thresholds for initiating HIV treatment on quality-adjusted life expectancy: a decision model." Annals of internal medicine 148, no. 3 (2008): 178-85. Abstract
"Emergency department use among HIV-infected released jail detainees." Journal of urban health : bulletin of the New York Academy of Medicine 92, no. 1 (2015): 108-35. Abstract
"Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies." PLoS medicine 11, no. 9 (2014): e1001718. Abstract
